Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.3
Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Aug. 31, 2019
Aug. 31, 2018
Aug. 31, 2019
Aug. 31, 2018
SALES $ 307,101 $ 53,257 $ 423,977 $ 220,115
COST OF SALES (247,679) (29,302) (328,512) (148,515)
GROSS PROFIT 59,422 23,955 95,465 71,600
EXPENSES:        
Depreciation 7,848 5,379 24,869 12,138
Amortization of patent rights 1,833 1,833 5,499 1,833
Foreign currency translation (gain) loss 349 (5,898) (15,372) (17,498)
Selling, general and administration 755,545 385,556 2,582,406 1,091,424
TOTAL OPERATING EXPENSES 765,575 386,870 2,597,402 1,087,897
LOSS FROM OPERATIONS (706,153) (362,915) (2,501,937) (1,016,297)
Accretion (367,457) (29,991) (672,517) (88,102)
Change in fair value of derivative liabilities 96,339 307,201 742,106 245,852
Other expense- Interest (109,572) (32,946) (256,998) (100,125)
LOSS BEFORE INCOME TAXES (1,086,843) (118,651) (2,689,346) (958,672)
Income taxes 0 0 0 0
NET LOSS (1,086,843) (118,651) (2,689,346) (958,672)
Foreign exchange translation adjustment for the period (52,089) (4,922) (80,208) (7,175)
COMPREHENSIVE LOSS $ (1,138,932) $ (123,573) $ (2,769,554) $ (965,847)
Loss per share - basic and diluted $ (0.01) $ (0.001) $ (0.026) $ (0.01)
Weighted average number of common shares outstanding 104,071,705 94,357,643 103,386,825 93,559,755